Login / Signup

Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.

Shawn L Hervey-JumperYalan ZhangJoanna J PhillipsRamin A MorshedJacob S YoungLucie McCoyMarisa LafontaineTracy LuksSimon AmmanuelSofia KakaizadaAndrew EgladyousAndrew GogosJavier E Villanueva-MeyerAnny ShaiGayathri WarrierTerri RiceJason C CraneMargaret WrenschJohn K WienckeMariza DarasNancy Ann Oberheim BushJennie W TaylorNicholas A ButowskiJennifer ClarkeSusan ChangEdward F ChangManish AghiPhilip TheodosopoulosMichael McDermottAsgeir Store JakolaVasileios K KavouridisNoah NawabiOle Skeidsvoll SolheimTimothy SmithMitchel S BergerAnnette M Molinaro
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Across both subtypes of LGG, EOR beginning at 75% improves OS while beginning at 80% improves progression-free survival. Nonetheless, maximal resection with preservation of neurological function remains the treatment goal. Our findings have implications for surgical strategies for LGGs, particularly oligodendroglioma.
Keyphrases
  • low grade
  • free survival
  • high grade
  • case report
  • heart rate
  • resistance training
  • blood pressure
  • body composition
  • single molecule
  • brain injury
  • subarachnoid hemorrhage
  • replacement therapy